相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Evaluating cell lines as models for metastatic breast cancer through integrative analysis of genomic data
Ke Liu et al.
NATURE COMMUNICATIONS (2019)
Identification of inhibitors synergizing gemcitabine sensitivity in the squamous subtype of pancreatic ductal adenocarcinoma (PDAC)
Jia Lin Er et al.
APOPTOSIS (2018)
Plasticity and intratumoural heterogeneity of cell surface antigen expression in breast cancer
Jan Remsik et al.
BRITISH JOURNAL OF CANCER (2018)
Aglycone Polyether Nanchangmycin and Its Homologues Exhibit Apoptotic and Antiproliferative Activities against Cancer Stem Cells
Minjian Huang et al.
ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE (2018)
The HDAC Inhibitor Quisinostat (JNJ-26481585) Supresses Hepatocellular Carcinoma alone and Synergistically in Combination with Sorafenib by G0/G1 phase arrest and Apoptosis induction
Bin He et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2018)
Identification of a cancer stem cell-specific function for the histone deacetylases, HDAC1 and HDAC7, in breast and ovarian cancer
A. E. Witt et al.
ONCOGENE (2017)
Cancer stem cells revisited
Eduard Batlle et al.
NATURE MEDICINE (2017)
EMT, CSCs, and drug resistance: the mechanistic link and clinical implications
Tsukasa Shibue et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
C-SPADE: a web-tool for interactive analysis and visualization of drug screening experiments through compound-specific bioactivity dendrograms
Balaguru Ravikumar et al.
NUCLEIC ACIDS RESEARCH (2017)
YM155 as an inhibitor of cancer stemness simultaneously inhibits autophosphorylation of epidermal growth factor receptor and G9a-mediated stemness in lung cancer cells
Chun-Chia Cheng et al.
PLOS ONE (2017)
Acetylation and deacetylation in cancer stem-like cells
Na Liu et al.
ONCOTARGET (2017)
Breast Cancer Cell Line Classification and Its Relevance with Breast Tumor Subtyping
Xiaofeng Dai et al.
JOURNAL OF CANCER (2017)
Cudraflavone C Induces Tumor-Specific Apoptosis in Colorectal Cancer Cells through Inhibition of the Phosphoinositide 3-Kinase (PI3K)-AKT Pathway
Hsien-Chuen Soo et al.
PLOS ONE (2017)
Jerantinine A induces tumor-specific cell death through modulation of splicing factor 3b subunit 1 (SF3B1)
Felicia Fei-Lei Chung et al.
SCIENTIFIC REPORTS (2017)
Unraveling the roles of CD44/CD24 and ALDH1 as cancer stem cell markers in tumorigenesis and metastasis
Wenzhe Li et al.
SCIENTIFIC REPORTS (2017)
A multicenter phase II study of the efficacy and safety of quisinostat (an HDAC inhibitor) in combination with paclitaxel and carboplatin chemotherapy (CT) in patients (pts) with recurrent platinum resistant high grade serous epithelial ovarian, primarily peritoneal or fallopian tube carcinoma cancer (OC).
Sergei Tjulandin et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Combenefit: an interactive platform for the analysis and visualization of drug combinations
Giovanni Y. Di Veroli et al.
BIOINFORMATICS (2016)
Inhibition of histone deacetylases in cancer therapy: lessons from leukaemia
Elena Ceccacci et al.
BRITISH JOURNAL OF CANCER (2016)
Combining Epigenetic and Immunotherapy to Combat Cancer
Katherine B. Chiappinelli et al.
CANCER RESEARCH (2016)
Fibroblast growth factor receptor 4 (FGFR4) and fibroblast growth factor 19 (FGF19) autocrine enhance breast cancer cells survival
Kai Hung Tiong et al.
ONCOTARGET (2016)
Cancer Stem Cell Plasticity Drives Therapeutic Resistance
Mary R. Doherty et al.
CANCERS (2016)
Metformin synergizes 5-fluorouracil, epirubicin, and cyclophosphamide (FEC) combination therapy through impairing intracellular ATP production and DNA repair in breast cancer stem cells
Jaslyn Sian-Siu Soo et al.
APOPTOSIS (2015)
Antitumour benzothiazoles. Part 32: DNA adducts and double strand breaks correlate with activity; synthesis of 5F203 hydrogels for local delivery
Erica L. Stone et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2015)
Novel Histone Deacetylase Inhibitors Induce Growth Arrest, Apoptosis, and Differentiation in Sarcoma Cancer Stem Cells
Gemma Di Pompo et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Melanoma cells influence the differentiation pattern of human epidermal keratinocytes
Ondrej Kodet et al.
MOLECULAR CANCER (2015)
Distinct EMT programs control normal mammary stem cells and tumour-initiating cells
Xin Ye et al.
NATURE (2015)
Single-cell analysis reveals a stem-cell program in human metastatic breast cancer cells
Devon A. Lawson et al.
NATURE (2015)
Nutlin-3 sensitizes nasopharyngeal carcinoma cells to cisplatin-induced cytotoxicity
Yee-Lin Voon et al.
ONCOLOGY REPORTS (2015)
The mitotic kinesin KIF11 is a driver of invasion, proliferation, and self-renewal in glioblastoma
Monica Venere et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
YM155 potently triggers cell death in breast cancer cells through an autophagy-NF-kB network
Eloise Vequaud et al.
ONCOTARGET (2015)
Expression of Histone Deacetylases HDAC1, HDAC2, HDAC3, and HDAC6 in Invasive Ductal Carcinomas of the Breast
Jinwon Seo et al.
JOURNAL OF BREAST CANCER (2014)
New and emerging HDAC inhibitors for cancer treatment
Alison C. West et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Selective Activity of the Histone Deacetylase Inhibitor AR-42 against Leukemia Stem Cells: A Novel Potential Strategy in Acute Myelogenous Leukemia
Monica L. Guzman et al.
MOLECULAR CANCER THERAPEUTICS (2014)
Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders
Katrina J. Falkenberg et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
Metformin and phenformin deplete tricarboxylic acid cycle and glycolytic intermediates during cell transformation and NTPs in cancer stem cells
Andreas Janzer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Erasers of Histone Acetylation: The Histone Deacetylase Enzymes
Edward Seto et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2014)
A possible usage of a CDK4 inhibitor for breast cancer stem cell-targeted therapy
Yu Kyeong Han et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2013)
Differential expression of histone deacetylases HDAC1, 2 and 3 in human breast cancer - overexpression of HDAC2 and HDAC3 is associated with clinicopathological indicators of disease progression
Berit Maria Mueller et al.
BMC CANCER (2013)
The Histone Deacetylase Inhibitor Abexinostat Induces Cancer Stem Cells Differentiation in Breast Cancer with Low Xist Expression
Marion A. Salvador et al.
CLINICAL CANCER RESEARCH (2013)
A Phase I Study of Quisinostat (JNJ-26481585), an Oral Hydroxamate Histone Deacetylase Inhibitor with Evidence of Target Modulation and Antitumor Activity, in Patients with Advanced Solid Tumors
Balaji Venugopal et al.
CLINICAL CANCER RESEARCH (2013)
The expression and significance of insulin-like growth factor-1 receptor and its pathway on breast cancer stem/progenitors
Wen-Wei Chang et al.
BREAST CANCER RESEARCH (2013)
Suppression of BCL-2 synergizes cisplatin sensitivity in nasopharyngeal carcinoma cells
Soon Yang Low et al.
CANCER LETTERS (2012)
Efficacy of everolimus, a novel mTOR inhibitor, against basal-like triple-negative breast cancer cells
Mayu Yunokawa et al.
CANCER SCIENCE (2012)
Epigenetic protein families: a new frontier for drug discovery
Cheryl H. Arrowsmith et al.
NATURE REVIEWS DRUG DISCOVERY (2012)
Antitumor effect of the mTOR inhibitor everolimus in combination with trastuzumab on human breast cancer stem cells in vitro and in vivo
Yuanxi Zhu et al.
TUMOR BIOLOGY (2012)
Roles of histone deacetylases in epigenetic regulation: emerging paradigms from studies with inhibitors
Genevieve P. Delcuve et al.
CLINICAL EPIGENETICS (2012)
Histone Deacetylase Inhibitors in Cell Pluripotency, Differentiation, and Reprogramming
Androniki Kretsovali et al.
STEM CELLS INTERNATIONAL (2012)
Rapamycin synergizes cisplatin sensitivity in basal-like breast cancer cells through up-regulation of p73
Su Wei Wong et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
The anti-diabetic drug metformin suppresses self-renewal and proliferation of trastuzumab-resistant tumor-initiating breast cancer stem cells
Alejandro Vazquez-Martin et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
Metformin Decreases the Dose of Chemotherapy for Prolonging Tumor Remission in Mouse Xenografts Involving Multiple Cancer Cell Types
Dimitrios Iliopoulos et al.
CANCER RESEARCH (2011)
HDAC6 is required for invadopodia activity and invasion by breast tumor cells
Mercedes Rey et al.
EUROPEAN JOURNAL OF CELL BIOLOGY (2011)
Next-generation mTOR inhibitors in clinical oncology: how pathway complexity informs therapeutic strategy
Seth A. Wander et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Targeting Epigenetic Regulation of miR-34a for Treatment of Pancreatic Cancer by Inhibition of Pancreatic Cancer Stem Cells
Dara Nalls et al.
PLOS ONE (2011)
Normal and neoplastic nonstem cells can spontaneously convert to a stem-like state
Christine L. Chaffer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Drug Combination Studies and Their Synergy Quantification Using the Chou-Talalay Method
Ting-Chao Chou
CANCER RESEARCH (2010)
Insulin-like growth factor 1 (IGF1), IGF binding protein 3 (IGFBP3), and breast cancer risk: pooled individual data analysis of 17 prospective studies
Timothy J. Key et al.
LANCET ONCOLOGY (2010)
Metformin Selectively Targets Cancer Stem Cells, and Acts Together with Chemotherapy to Block Tumor Growth and Prolong Remission
Heather A. Hirsch et al.
CANCER RESEARCH (2009)
Breast Cancer Cell Lines Contain Functional Cancer Stem Cells with Metastatic Capacity and a Distinct Molecular Signature
Emmanuelle Charafe-Jauffret et al.
CANCER RESEARCH (2009)
Identification of Selective Inhibitors of Cancer Stem Cells by High-Throughput Screening
Piyush B. Gupta et al.
CELL (2009)
Human breast cancer cell lines contain stem-like cells that self-renew, give rise to phenotypically diverse progeny and survive chemotherapy
Christine M. Fillmore et al.
BREAST CANCER RESEARCH (2008)
The CDK inhibitors: potential targets for therapeutic stem cell manipulations?
M. J. Boyer et al.
GENE THERAPY (2008)
Activation of the PTEN/mTOR/STAT3 pathway in breast cancer stem-like cells is required for viability and maintenance
Jiangbing Zhou et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
A probability-based approach for the analysis of large-scale RNAi screens
Renate Koenig et al.
NATURE METHODS (2007)
A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes
Richard M. Neve et al.
CANCER CELL (2006)
Anticancer activities of histone deacetylase inhibitors
Jessica E. Bolden et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
Quantitation of HDAC1 mRNA expression in invasive carcinoma of the breast
ZH Zhang et al.
BREAST CANCER RESEARCH AND TREATMENT (2005)
Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties
D Ponti et al.
CANCER RESEARCH (2005)
Role of Class I and Class II histone deacetylases in carcinoma cells using siRNA
KB Glaser et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2003)
Prospective identification of tumorigenic breast cancer cells
M Al-Hajj et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
分享论文
